C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/1994
11/23/1994	EP0625197A1 Dna encoding kappa-casein, process for obtaining the protein and use thereof
11/23/1994	EP0625193A1 Insecticidally effective peptides
11/23/1994	EP0625159A1 Ikaros: a t cell pathway regulatory gene
11/23/1994	EP0625052A1 Bacterial expression vectors containing dna encoding secretion signals of lipoproteins
11/23/1994	EP0625051A1 Hepatic growth factor receptor
11/23/1994	EP0625049A1 Ex vivo gene transfer
11/23/1994	EP0625048A1 Synthesis of human procollagens and collagens in recombinant dna systems
11/23/1994	EP0625047A1 Platelet transfusion
11/23/1994	EP0556320A4 Monoclonal antibodies to hepatitis c virus and method for using same
11/23/1994	EP0535088A4 Chimeric toxins with improved inter-domain geometry
11/23/1994	EP0464101B1 Improvements relating to the radio-labelling of proteins
11/22/1994	US5367059 Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor
11/22/1994	US5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/22/1994	US5366888 Enhanced maintenance of pregnancy using leukaemia inhibitory factor in embryo culturing
11/22/1994	US5366866 Screening for cancer with antibodies
11/22/1994	US5366862 Exposing protein to proteolytic enzymes to degrade; scrambling, binding target, removing, and sequencing
11/22/1994	CA1333162C Method for the expression of genes in yeast, and dna fragments as well as plasmids comprising said dna fragments to be used when carrying out the method
11/22/1994	CA1333150C Method for the control of pneumocystis carinii
11/17/1994	EP0624650A2 FemB gene of Staphylococcus epidermidis, FemB protein, and vectors and microorganisms comprising the FemB gen
11/17/1994	EP0624649A1 Polypeptide derived from a human glioblastoma cell line and DNA's encoding it
11/17/1994	EP0624648A1 Polypeptide derived form a human glioblastoma cell line and DNA's encoding it
11/17/1994	EP0624647A1 Polypeptide derived from a human gliobastoma cell line and DNAs encoding it
11/17/1994	EP0624646A1 Polypeptide derived from a human glioblastomer cell line and DNA's encoding it
11/17/1994	EP0624645A1 Human chondromodulin-I protein
11/17/1994	EP0624644A1 DNA fragment, vector containing the DNA fragment, transformant transformed with the vector and process for producing protein using the vector
11/17/1994	EP0624642A1 Novel thrombolytic agent, process for preparing same and its use for the preparation of a thrombi dissolving medicament
11/17/1994	EP0624598A1 Hepatitis B-binding factor
11/17/1994	EP0624376A1 Preparation and uses of LOS-depleted outer membrane proteins of gram-negative cocci
11/17/1994	EP0624201A1 Method for producing soluble t-receptors by co-transfection, and use of resulting products
11/17/1994	EP0624200A1 New polypeptides having granulocyte colony stimulating activity, preparation thereof and pharmaceutical compositions containing said polypeptides
11/17/1994	EP0624198A1 Synthetic peptides for a rubella vaccine
11/17/1994	EP0624196A1 Polypeptides with fibronectin binding sites as modulators for matrix assembly.
11/17/1994	EP0624195A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
11/17/1994	EP0624194A1 Polypeptides derived from human aiv apolipoprotein, preparation and use thereof
11/17/1994	EP0624193A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins
11/17/1994	EP0624100A1 Dna encoding a human serotonin receptor (5-ht 4b?) and uses thereof
11/17/1994	EP0563280B1 Tissue plasminogen activator substitution variant
11/17/1994	EP0531448B1 Mammalian expression of the bmp-2 family
11/17/1994	EP0109441B1 Human-human hybridomas for neoplasms
11/16/1994	CN1095106A Vaccines
11/16/1994	CN1094965A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
11/15/1994	US5364793 Methods for the diagnosis of peripheral nerve damage
11/15/1994	US5364774 Isolation of polynucleotides like DNA, hybridization and degeneration
11/15/1994	US5364771 Genetic engineering
11/15/1994	US5364624 Inhibitors of human leukocyte elastase, treatment of cystic fibrosis
11/15/1994	CA2123364A1 Process for purification of water soluble penicillin binding protein 2a
11/12/1994	CA2123252A1 Polypeptide and dnas encoding it
11/12/1994	CA2123251A1 Polypeptide and dnas encoding it
11/12/1994	CA2123250A1 Polypeptide and dnas encoding it
11/12/1994	CA2123249A1 Polypeptide and dnas encoding it
11/12/1994	CA2122937A1 Human chondromodulin-i protein
11/10/1994	WO1994025617A2 Monoclonal antibodies against ck-mb
11/10/1994	WO1994025616A1 Cell-targeted lytic pore-forming agents
11/10/1994	WO1994025612A2 Nucleotide sequences for the control of the expression of dna sequences in a cellular host
11/10/1994	WO1994025606A2 Recombinant alanine racemase and gapdh from tolypocladium
11/10/1994	WO1994025602A1 Hepatitis-c virus type 4, 5 and 6
11/10/1994	WO1994025599A1 Mammal cell lines and method of obtaining glycoproteins
11/10/1994	WO1994025598A2 Methods and compositions for salmonella-based vaccines
11/10/1994	WO1994025597A2 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA)
11/10/1994	WO1994025596A2 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS
11/10/1994	WO1994025592A1 A novel gene coding human epidermal growth factor and process for preparing the same
11/10/1994	WO1994025591A1 PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
11/10/1994	WO1994025585A1 Transgenic non-human animals capable of producing heterologous antibodies
11/10/1994	WO1994025582A1 Method of enhancing thrombolysis
11/10/1994	WO1994025580A1 A method for hydrolysing proteins
11/10/1994	WO1994025568A1 Cold-tolerant strains of rhizobium species
11/10/1994	WO1994025565A1 HUMAN $i(SYK)
11/10/1994	WO1994025491A1 Fibrin-targeted inhibitors of thrombin
11/10/1994	WO1994025486A1 Improved hcv diagnostic agents
11/10/1994	WO1994025483A1 Immunotherapeutic peptides derived from toxic shock syndrome toxin-1, antibodies thereto, their uses in pharmaceutical compositions and diagnosis
11/10/1994	WO1994025072A1 Rapamycin conjugates and antibodies
11/10/1994	WO1994025067A1 Antibodies to p-selectin and their uses
11/10/1994	WO1994025066A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
11/10/1994	WO1994025064A1 Hepatitis c virus cell propagation and related methods
11/10/1994	WO1994025060A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
11/10/1994	WO1994025055A1 Erythropoietin analog compositions and methods
11/10/1994	WO1994025047A1 Inhibition of leukocyte adhesion
11/10/1994	WO1994025022A1 Rapamycin conjugates and antibodies
11/10/1994	WO1994025000A1 Hookworm anticoagulant
11/10/1994	WO1994024959A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage
11/10/1994	WO1994024870A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites
11/10/1994	WO1994023030A3 Methods and materials relating to the functional domains of dna binding proteins
11/10/1994	WO1994021812A3 Hepatitis b escape mutant specific binding molecules
11/10/1994	WO1994021800A3 Protein tyrosine phosphatase ptp-s31
11/10/1994	WO1994021781A3 Extracellular signal-regulated kinase, sequences, and methods of production and use
11/10/1994	WO1994021675A3 T cell epitopes of ryegrass pollen allergen
11/10/1994	WO1994017193A3 Chimeric l- and p-selectin by exchange of domains - uses thereof
11/10/1994	WO1994013812A3 Novel entomopoxvirus genes, proteins and methods of use thereof
11/10/1994	WO1994003075A3 Morphogen-enriched dietary composition
11/10/1994	CA2162158A1 Nucleotide sequences for the control of the expression of dna sequences in a cellular host
11/10/1994	CA2162056A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites
11/10/1994	CA2161796A1 Hookworm anticoagulant
11/10/1994	CA2161772A1 Fibrin-targeted inhibitors of thrombin
11/10/1994	CA2161656A1 Combined treatment of iron depletion and igg antibody
11/10/1994	CA2161651A1 Erythropoietin analog compositions and methods
11/10/1994	CA2161534A1 Immunogenic formulation of ospc antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
11/10/1994	CA2161517A1 Mammalian cell lines and method of obtaining glycoproteins
11/10/1994	CA2161405A1 Methods and compositions for detection of salmonella
11/10/1994	CA2161404A1 Methods and compositions for salmonella-based vaccines
11/10/1994	CA2161101A1 Rapamycin conjugates and antibodies

1 ... 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 ... 1125